IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traverso, V.
Right arrow Articles by Deretic, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traverso, V.
Right arrow Articles by Deretic, D.
(Investigative Ophthalmology and Visual Science. 2002;43:1655-1661.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Retinal cAMP Levels during the Progression of Retinal Degeneration in Rhodopsin P23H and S334ter Transgenic Rats

Valerie Traverso1, Ronald A. Bush1, Paul A. Sieving1 and Dusanka Deretic1,2

1 From the Departments of Ophthalmology and Visual Sciences and 2 Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.

PURPOSE. To test whether high levels of cAMP promote apoptosis and shorten the life of retinal rod photoreceptors, the changes in cAMP levels during retinal degeneration were analyzed in two transgenic rat models that express rhodopsin P23H and S334ter mutations.

METHODS. Dark- and light-adapted heterozygous P23H (lines 1 and 3; P23H-1 and -3), S334ter line 4 (S334ter-4), and Sprague-Dawley (control) rats were studied at 4 to 8 weeks by cAMP enzyme competitive immunoassay and by cAMP immunocytochemistry.

RESULTS. In control animals retinal cAMP content reached a steady state level at 30 days of age. Dark-adapted control retinas had up to 97% higher cAMP content than light-adapted retinas, and photoreceptor cells were the major source of this increase. Dark-adapted photoreceptors in all three lines of transgenic rats at advanced stages of retinal degeneration had cAMP content different from that of the control. In rats that express mutant rhodopsin, the number of photoreceptor cells was progressively reduced, because of retinal degeneration, but dark-adapted cAMP levels did not decline accordingly. P23H transgenic animals of both lines had higher levels of cAMP per photoreceptor cell count than control animals. This elevation was more pronounced as degeneration progressed. S334ter animals showed smaller cAMP elevation than P23H rats at a similar stage of retinal degeneration, but at a point when S334ter rats were undergoing rapid retinal degeneration, whereas in P23H rats retinal degeneration was slowing down.

CONCLUSIONS. All three lines of transgenic rats carrying rhodopsin mutations show an increase in dark-adapted photoreceptor cAMP levels. A complex relationship exists between cAMP levels and the rate of cell death in the retina. Although initially higher levels of cAMP may promote cell survival and slow down retinal degeneration, ultimately, elevated cAMP levels may become toxic and may contribute to retinal cell death.




This article has been cited by other articles:


Home page
IOVSHome page
B. A. Berkowitz, M. Gradianu, S. Schafer, Y. Jin, A. Porchia, R. Iezzi, and R. Roberts
Ionic Dysregulatory Phenotyping of Pathologic Retinal Thinning with Manganese-Enhanced MRI
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3178 - 3184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Horner, S. Osawa, M. D. Schaller, and E. R. Weiss
Phosphorylation of GRK1 and GRK7 by cAMP-dependent Protein Kinase Attenuates Their Enzymatic Activities
J. Biol. Chem., August 5, 2005; 280(31): 28241 - 28250.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. A. Khodair, M. A. Zarbin, and E. Townes-Anderson
Cyclic AMP Prevents Retraction of Axon Terminals in Photoreceptors Prepared for Transplantation: An In Vitro Study
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 967 - 973.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology